A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

April 29, 2025

Primary Completion Date

August 17, 2027

Study Completion Date

August 17, 2027

Conditions
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Interventions
OTHER

No Intervention

This is a non-interventional study.

Trial Locations (15)

2100

RECRUITING

Rigshospitalet, København Ø

8200

RECRUITING

Arhus Universtitetshospital, Aarhus N

13347

NOT_YET_RECRUITING

Judisches Krankenhaus Berlin, Berlin

15562

RECRUITING

Immanuel Klinik Rudersdorf, Rüdersdorf

27157

RECRUITING

Wake Forest University - School of Medicine - Central, Winston-Salem

33713

NOT_YET_RECRUITING

Suncoast Neuroscience Associates, Inc., St. Petersburg

34209

RECRUITING

Nova Clinical Research, LLC, Bradenton

35043

NOT_YET_RECRUITING

Universitaetsklinikum Giessen und Marburg GmbH Standort Marburg, Marburg

44791

RECRUITING

Katholisches Klinikum Bochum gGmbH, Bochum

62269

RECRUITING

HSHS St. Elizabeths Hospital, O'Fallon

66160

RECRUITING

University of Kansas Medical Center Research Institute, Inc., Kansas City

92270

RECRUITING

Samir Macwan MD Inc, Rancho Mirage

94143

RECRUITING

Neuro/Psych Sleep Clinic, San Francisco

96817

RECRUITING

Hawaii Pacific Neuroscience, Honolulu

06510

NOT_YET_RECRUITING

Yale School Of Medicine, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT06538064 - A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care | Biotech Hunter | Biotech Hunter